%20CO.%2C%20LTD./other/ASSURE_TECH_HANGZHOU_CO._LTD.-logo.png){kind=logo}
ASSURE TECH (HANGZHOU) CO., LTD. — Investor Relations & Filings
Assure Tech (Hangzhou) Co., Ltd. is a biotechnology enterprise specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and clinical testing instruments. The company focuses on rapid diagnostic tests and Point of Care Testing (POCT) solutions across various medical fields, including infectious diseases, drug of abuse screening, oncology, cardiac markers, and fertility. Utilizing advanced lateral flow immunoassay technology, Assure Tech provides diagnostic tools designed for accuracy and efficiency in clinical and laboratory settings. The company adheres to international quality standards, maintaining ISO 13485 certification and obtaining regulatory clearances such as FDA and CE marks for its product range. Through its integrated R&D and production infrastructure, Assure Tech supplies a diverse portfolio of diagnostic products to a global customer base.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 安旭生物2025年年度股东会决议公告 | 2026-05-21 | Chinese | |
| 上海市锦天城律师事务所关于安旭生物2025年度股东会法律意见书 | 2026-05-21 | Chinese | |
| 上海锦天城（杭州）律师事务所关于安旭生物终止实施2024年限制性股票激励计划的法律意见书 | 2026-04-29 | Chinese | |
| 安旭生物关于召开2025年年度股东会的通知 | 2026-04-29 | Chinese | |
| 安旭生物2025年度独立董事述职报告（程乐） | 2026-04-29 | Chinese | |
| 安旭生物2025年度会计师事务所履职情况评估报告 | 2026-04-29 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46757227 | 安旭生物2025年年度股东会决议公告 | 2026-05-21 | Chinese | ||
| 46757225 | 上海市锦天城律师事务所关于安旭生物2025年度股东会法律意见书 | 2026-05-21 | Chinese | ||
| 44497843 | 上海锦天城（杭州）律师事务所关于安旭生物终止实施2024年限制性股票激励计划的法律意见书 | 2026-04-29 | Chinese | ||
| 44497821 | 安旭生物关于召开2025年年度股东会的通知 | 2026-04-29 | Chinese | ||
| 44497811 | 安旭生物2025年度独立董事述职报告（程乐） | 2026-04-29 | Chinese | ||
| 44497808 | 安旭生物2025年度会计师事务所履职情况评估报告 | 2026-04-29 | Chinese | ||
| 44497807 | 安旭生物董事和高级管理人员薪酬管理制度 | 2026-04-29 | Chinese | ||
| 44497802 | 安旭生物2025年度独立董事述职报告（周娟英已离任） | 2026-04-29 | Chinese | ||
| 44497794 | 安旭生物关于开展远期结售汇及外汇衍生品业务的公告 | 2026-04-29 | Chinese | ||
| 44497787 | 安旭生物董事和高级管理人员离职管理制度 | 2026-04-29 | Chinese | ||
| 44497782 | 安旭生物2025年度独立董事述职报告（章国标已离任） | 2026-04-29 | Chinese | ||
| 44497777 | 安旭生物2025年度利润分配预案的公告 | 2026-04-29 | Chinese | ||
| 44497766 | 安旭生物关于2026年度“提质增效重回报”行动方案的公告 | 2026-04-29 | Chinese | ||
| 44497765 | 安旭生物2025年度独立董事述职报告（戴文涛） | 2026-04-29 | Chinese | ||
| 44497758 | 安旭生物关于开展远期结售汇及外汇衍生产品业务的可行性分析报告 | 2026-04-29 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ASSURE TECH (HANGZHOU) CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58122/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58122 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58122 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58122 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58122}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ASSURE TECH (HANGZHOU) CO., LTD. (id: 58122)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.